Middle East and Africa Prebiotics for Infant Formula Market – Industry Trends and Forecast to 2027

  • Food & Beverage
  • Published Report
  • Dec 2019
  • MEA
  • 350 Pages
  • No of Tables: 102
  • No of Figures: 25

Middle East & Africa Prebiotics for Infant Formula By Type (Human Milk Oligosaccharides (HMOS), Galactooligosaccharides (GOS), Fructooligosaccharides (FOS), Mannan-Oligosaccharides (MOS), Polydextrose (PDX), Lactulose (LOS), Inulin), Source (Bacteria, Algae, Fungi, Plants & Vegetables), Grade (Inorganic, Organic), Form (Powder, Liquid), Product Type (Standard Formula, Toddler Formula, Follow Up Formula, Special Formula), Infant Age (0-6 Months, 6-12 Months, 1-3 Years), By Country (South Africa, U.A.E, Saudi Arabia, Oman, Kuwait and rest of Middle East & Africa), Market Trends and  Forecast to 2027

Market Analysis and Insights: Middle East and Africa Prebiotics for Infant Formula Market

Prebiotics for Infant Formula market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing at a CAGR of 5.3% in the forecast period of 2020 to 2027 and expected to reach USD 33.08 million by 2027. High utilization of the prebiotic ingredient in the infant formula and growing number of preterm birth in African region accelerates the growth of the market.

The growth in the number of infants and requirement of the nutritional food products for the growth and development of infant owe to the market growth. According to the world health organization (WHO), in 2018, in Asia and South Africa the preterm birth rate accounts more than 60% of total infant birth. The high chances of preterm birth in these regions require enough nutritional formulas to treat the preterm babies augmented to the market growth in forecast period.

This Prebiotics for Infant Formula market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Middle East & Africa Prebiotics for Infant Formula Market Scope and Market Size

Middle East & Africa prebiotics for infant formula market is segmented of the basis type, source, grade, form, product type and infant age. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the market is segmented into human milk oligosaccharides (HMOS), galactooligosaccharides (GOS), fructooligosaccharides (FOS), mannan-oligosaccharides (MOS), polydextrose (PDX), lactulose (LOS), and inulin. In 2020 Human milk oligosaccharides (HMOS) segment is expected to dominate the market and growing with highest CAGR due to their composition associated with the human milk and benefits adapted for the infant’s immature digestive and immune systems. The U.S. food and drug administration (FDA) have independently permitted the safety and utilization of lacto-N-neotetraose (LNnT) and 2′-fucosyllactose (2′-FL) for administration to babies with the help of infant formulas owing to their market growth.
  • On the basis of source, the market is segmented into bacteria, algae, fungi, plants & vegetables, and others. In 2020, plants & vegetables segment is expected to dominate the market due to the high yield of FOS & GOS from Barley, wheat and extraction of Inulin from Chicory roots. The Cargill Incorporated (U.S.) have developed blend of oligo fibre extracted from the Chicory roots used in the infant and other food products for health benefits. The preference of the manufacturers to use the plants and vegetables as source in the production of Prebiotics and their demand will leads to the market growth.
  • On the basis of grade, the market is segmented into inorganic and organic. In 2020, inorganic segment is expected to dominate the market and in Middle East & Africa and Organic is growing with the highest CAGR, due to the high cost of the organic products the consumers more focused towards the inorganics based infant formulas and rapid growth towards vegan population and safety associated with organic formulas leads population to prefer organic product lead to grow with highest CAGR.
  • On the basis of form, the market is segmented into powder and liquid. In 2020, powder segment is expected to dominate the market as according food additive safety (HFS-255), FOS is majorly marketed in form of granular form due to their stabili        ty and consistency to manufacture the infant formula in off-white color. With the stability and convenience in handling the powder form is mostly preferred among manufacturers than the liquid.
  • On the basis of product type, the market is segmented into standard formula, toddler formula, follow up formula and special formula. In 2020, standard formula segment is expected to dominate due to their similar efficiency in growth and development of infants and the formulation composition of prebiotics in standard formulas compare to other shows positive effect in developing the gut bacteria. The standard formula and their adoption among infants of age 0 to 12 months incorporated with FOS and GOS blends provide positive feedback and leading in their health growth
  • On the basis of infant age, the market is segmented into 0-6 months, 6-12 months and 1-3 years.  In 2020, 6-12 months segment is expected to dominate the global prebiotics for infant formula market due to demand of prebiotics is higher for 6 to 12 year age group of infants. Even several studies conducted by the research institution also prefer prebiotics for infant due to its enhanced growth benefits. Infants having age group of 6-12 months requires more content of carbohydrate, protein, vitamin and other nutrition to support their healthy growth.
  • In February 2014, United Arab Emirates (U.A.E.) federal national council has proposed a law in which requires their mother to feed their son until the child is of two years. The awareness among the working women was due to the lack of nutrition in infants. The new law will enforced population to adopt the mother feeding and use their mother milk substitutes such as HMO’s

Prebiotics for Infant Formula Market Country Level Analysis

Middle East & Africa market is analysed and market size information is provided by country by type, source, grade, form, product type and infant age as referenced above.

The countries covered in the Prebiotics for Infant Formula market report are U South Africa, U.A.E, Saudi Arabia, Oman, Kuwait and rest of Middle East & Africa in Middle East & Africa.

Middle East & Africa Prebiotics for Infant Formula market is dominating the market due to the initiatives taken by the companies engaged in infant formulas to market their products in Middle East region. For instance, In October 2019, BASF SE (Germany) entered in the Human milk oligosaccharides (HMOs) market by introducing new 2’-FL (2’-fucosyllactose) ingredient named as Prebilac. The company developed this product by partnering with Glycosyn. The products offer both nutritional as well as additional benefits for gastrointestinal health. Through this, the company has entered in the prebiotics for infant’s formula market.  

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Growth in Utilization of Clinical Laboratories

Middle East & Africa prebiotics for infant formula market also provides you with detailed market analysis for every country growth in installed base of different kind of products for electric vehicles market, impact of technology using life line curves and changes in infant formula regulatory scenarios and their impact on the Prebiotics for Infant Formula market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Prebiotics for Infant Formula Market Share Analysis

Middle East & Africa Prebiotics for Infant Formula market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, brand analysis, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Middle East & Africa prebiotics for infant formula market.

The major players covered in the report are Jennewein Biotechnologie GmbH, zuChem Inc., Biosynth Carbosynth, ELICITYL SA, Dextra Laboratories Limited, Glycom A/S, Tereos, Ingredion Incorporated, Royal FrieslandCampina N.V., Südzucker AG, Cargill, Incorporated., Fonterra Co-operative Group, Royal Cosun, COSUCRA, New Francisco (Yunfu City) Biotechnology Corporation Limited, Dana Dairy Group, Glycosyn LLC and DuPont among other players domestic and global. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

For instance,

  • In July 2018, Dana dairy group showcased their infant nutrition at CBME 2018 exhibition which was conducted at Shanghai, China. The company showcased their infant portfolio range including , baby biscuits, infant formulae, and infant cereals for Asian market. The introduction of new product DANALAC GOLD will expand their customer based in Asian Market.  
  • In April 2015, Tereos Starch & Sweeteners showcased their product portfolio in Chinese market. A division of company participated in Food Ingredients exhibition conducted at Shanghai, China. The presence of the company in exhibition will enhance their product visibility among Chinese consumers and enhances their customer base.

Partnership, collaboration and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for electric vehicles through expanded model range

Customization Available : Middle East and Africa Prebiotics for Infant Formula Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 2 MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 3 MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 4 MIDDLE EAST & AFRICA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 5 MIDDLE EAST & AFRICA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 6 MIDDLE EAST & AFRICA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 7 MIDDLE EAST & AFRICA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 8 MIDDLE EAST & AFRICA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA INULIN IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA POLYDEXTROSE (PDX) IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA MANNAN-OLIGOSACCHARIDES (MOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA LACTULOSE (LOS) IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA BACTERIA IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA FUNGI IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA ALGAE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA OTHERS IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA INORGANIC IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA ORGANIC IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA POWDER IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA LIQUID IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA STANDARD FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA SPECIAL FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA FOLLOW UP FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA TODDLER FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA 6-12 MONTHS IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA 0-6 MONTHS IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA 1-3 YEARS IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET,  BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET,  BY GRADE, 2018-2027 (USD MILLION)

TABLE 44 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET,  BY FORM, 2018-2027 (USD MILLION)

TABLE 45 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET,  BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 46 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET,  BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 47 SOUTH AFRICA PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 48 SOUTH AFRICA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 49 SOUTH AFRICA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 50 SOUTH AFRICA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 51 SOUTH AFRICA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 52 SOUTH AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 53 SOUTH AFRICA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 54 SOUTH AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 55 SOUTH AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 56 SOUTH AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 57 SOUTH AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 58 U.A.E. PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 59 U.A.E. HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 60 U.A.E. FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 61 U.A.E. GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 62 U.A.E. FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 63 U.A.E. PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 64 U.A.E. PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 65 U.A.E. PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 66 U.A.E. PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 67 U.A.E. PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 68 U.A.E. PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 69 SAUDI ARABIA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 70 SAUDI ARABIA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 71 SAUDI ARABIA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 72 SAUDI ARABIA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 73 SAUDI ARABIA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 74 SAUDI ARABIA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 75 SAUDI ARABIA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 76 SAUDI ARABIA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 77 SAUDI ARABIA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 78 SAUDI ARABIA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 79 SAUDI ARABIA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 80 OMAN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 81 OMAN HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 82 OMAN FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 83 OMAN GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 84 OMAN FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 85 OMAN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 86 OMAN PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 87 OMAN PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 88 OMAN PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 89 OMAN PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 90 OMAN PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 91 KUWAIT PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 92 KUWAIT HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 93 KUWAIT FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 94 KUWAIT GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 95 KUWAIT FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 96 KUWAIT PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 97 KUWAIT PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 98 KUWAIT PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 99 KUWAIT PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 100 KUWAIT PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 101 KUWAIT PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 102 REST OF MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19